Difficulty: Medium
Average Score: 89%
Practice
Medical management of patient with TB (DOTS).
Correct answer
C
Rationale
In the medical management of a patient with tuberculosis (TB), the most effective approach is the use of Directly Observed Treatment, Short-Course (DOTS) which involves a combination of antibiotics. Option C, "Both A and B" (Isoniazid and Rifampicin), is the correct answer because these two drugs are essential components of the first-line treatment for TB. Isoniazid works by inhibiting the synthesis of mycolic acids in the cell wall of the TB bacteria, while Rifampicin targets the RNA polymerase enzyme, disrupting bacterial RNA synthesis.
Option A, Isoniazid alone, is incorrect because monotherapy with Isoniazid can lead to the development of drug-resistant TB strains. Option B, Rifampicin alone, is also incorrect as monotherapy with Rifampicin is not recommended due to the high risk of developing drug resistance. Option D, "None of the above," is incorrect as the standard of care for TB treatment involves a combination of antibiotics to prevent the development of drug resistance and ensure effective treatment.
Educationally, understanding the rationale behind the use of combination therapy in TB treatment is crucial for healthcare providers to provide optimal care for their patients. It is essential to emphasize the importance of completing the full course of DOTS therapy to prevent treatment failure and the emergence of drug-resistant TB strains. Educating healthcare professionals on evidence-based treatment protocols for TB is vital in reducing the global burden of this infectious disease.
Option A, Isoniazid alone, is incorrect because monotherapy with Isoniazid can lead to the development of drug-resistant TB strains. Option B, Rifampicin alone, is also incorrect as monotherapy with Rifampicin is not recommended due to the high risk of developing drug resistance. Option D, "None of the above," is incorrect as the standard of care for TB treatment involves a combination of antibiotics to prevent the development of drug resistance and ensure effective treatment.
Educationally, understanding the rationale behind the use of combination therapy in TB treatment is crucial for healthcare providers to provide optimal care for their patients. It is essential to emphasize the importance of completing the full course of DOTS therapy to prevent treatment failure and the emergence of drug-resistant TB strains. Educating healthcare professionals on evidence-based treatment protocols for TB is vital in reducing the global burden of this infectious disease.